

 



<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
  "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml"
      xmlns:foaf="http://xmlns.com/foaf/0.1/"
      xmlns:dc="http://purl.org/dc/terms/"
      xmlns:doi="http://dx.doi.org/"
      xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
      xmlns:xsd="http://www.w3.org/2001/XMLSchema-datatypes#"
      lang="en" xml:lang="en"
      itemscope itemtype="http://schema.org/Article"
      class="no-js">
<head prefix="og: http://ogp.me/ns#">
  <title>PLOS ONE: Cerebrospinal Fluid Viral Load and Intrathecal Immune Activation in Individuals Infected with Different HIV-1 Genetic Subtypes</title>


<link rel="stylesheet" type="text/css"  href="/css/global-min.css?v=izteQ6tu7kgsJZW_xmrYizvKiHM" />


    <!--[if lte IE 7]>
<link rel="stylesheet" type="text/css"  href="/css/lte_ie7-min.css?v=3bykQUyQmReeuobVyPozcJ9LxRc" />
    <![endif]-->


<link rel="stylesheet" type="text/css"  href="/css/jquery-ui-min.css?v=eXDHTEJM0lIAmDe5k0I0Ad4nxNo" />


<link rel="stylesheet" type="text/css"  href="/css/journal.css?v=T7ZVxJfgk9jNxLAJ2qHz1vZpgYU" />


<link rel="stylesheet" type="text/css" media="print" href="/css/print-min.css?v=T5lb0B3q6EXBsuDluc5V5w+AkRc" />


  <link rel="stylesheet" href="http://f.fontdeck.com/s/css/js/www.plosone.org/24557.css" type="text/css"/>

  <!--chartbeat -->
  <script type="text/javascript">var _sf_startpt = (new Date()).getTime()</script>
  <script>document.documentElement.className += ' js';</script>

  <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
  <meta http-equiv="X-UA-Compatible" content="IE=EmulateIE7; IE=EmulateIE9"/>
  <meta name="description" content="PLOS ONE: an inclusive, peer-reviewed, open-access resource from the PUBLIC LIBRARY OF SCIENCE. Reports of well-performed scientific studies from all disciplines freely available to the whole world."/>
  <meta name="keywords" content="PLOS, Public Library of Science, Open Access, Open-Access, Science, Medicine, Biology, Research, Peer-review, Inclusive, Interdisciplinary, Ante-disciplinary, Physics, Chemistry, Engineering"/>
  <meta name="almHost" content="http://alm.plos.org/api/v3/articles"/>
  <meta name="searchHost" content="http://api.plos.org/search" />
  <meta name="termsHost" content="http://api.plos.org/terms" />
  <meta name="solrApiKey" content="plos"/>
  <meta name="almAPIKey" content="3pezRBRXdyzYW6ztfwft" />
  <meta name="currentJournal" content="PLoSONE" />
  <meta name="almRequestBatchSize" content="" />

  <meta name="citation_publisher" content="Public Library of Science"/>
  <meta name="citation_doi" content="10.1371/journal.pone.0001971"/>
  <meta name="dc.identifier" content="10.1371/journal.pone.0001971" />

    <meta name="citation_title" content="Cerebrospinal Fluid Viral Load and Intrathecal Immune Activation in Individuals Infected with Different HIV-1 Genetic Subtypes"/>
    <meta itemprop="name" content="Cerebrospinal Fluid Viral Load and Intrathecal Immune Activation in Individuals Infected with Different HIV-1 Genetic Subtypes"/>

      <meta name="citation_author" content="Sahra Abdulle"/>
            <meta name="citation_author_institution" content="Department of Infectious Diseases, The Sahlgrenska Academy, Göteborg University, Göteborg, Sweden"/>
      <meta name="citation_author" content="Lars Hagberg"/>
            <meta name="citation_author_institution" content="Department of Infectious Diseases, The Sahlgrenska Academy, Göteborg University, Göteborg, Sweden"/>
      <meta name="citation_author" content="Bo Svennerholm"/>
            <meta name="citation_author_institution" content="Department of Virology, The Sahlgrenska Academy, Göteborg University, Göteborg, Sweden"/>
      <meta name="citation_author" content="Dietmar Fuchs"/>
            <meta name="citation_author_institution" content="Division of Biological Chemistry, Biocentre, Innsbruck Medical University & Ludwig Boltzmann Institute of AIDS Research, Innsbruck, Austria"/>
      <meta name="citation_author" content="Magnus Gisslén"/>
            <meta name="citation_author_institution" content="Department of Infectious Diseases, The Sahlgrenska Academy, Göteborg University, Göteborg, Sweden"/>

    <meta name="citation_date" content="2008/4/16"/>

  <meta name="citation_pdf_url" content="http://dx.plos.org/10.1371/journal.pone.0001971.pdf" />

      <meta name="citation_journal_title" content="PLOS ONE" />
    <meta name="citation_firstpage" content="e1971"/>
    <meta name="citation_issue" content="4"/>
    <meta name="citation_volume" content="3"/>
    <meta name="citation_issn" content="1932-6203"/>

    <meta name="citation_journal_abbrev" content="PLoS ONE" />

      <meta name="citation_reference" content="citation_title=HIV-1 subtypes: epidemiology and significance for HIV management.; citation_author=AM Geretti; citation_journal_title=Curr Opin Infect Dis; citation_volume=19; citation_number=1; citation_pages=1-7; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Similar rate of disease progression among individuals infected with HIV-1 genetic subtypes A-D.; citation_author=A Alaeus; citation_author=K Lidman; citation_author=A Bjorkman; citation_author=J Giesecke; citation_author=J Albert; citation_journal_title=Aids; citation_volume=13; citation_number=2; citation_pages=901-907; citation_date=1999; " />
      <meta name="citation_reference" content="citation_title=Clinical disease associated with HIV-1 subtype B' and E infection among 2104 patients in Thailand.; citation_author=PN Amornkul; citation_author=S Tansuphasawadikul; citation_author=K Limpakarnjanarat; citation_author=S Likanonsakul; citation_author=N Young; citation_journal_title=Aids; citation_volume=13; citation_number=3; citation_pages=1963-1969; citation_date=1999; " />
      <meta name="citation_reference" content="citation_title=Relationship between HIV-1 Env subtypes A and D and disease progression in a rural Ugandan cohort.; citation_author=P Kaleebu; citation_author=A Ross; citation_author=D Morgan; citation_author=D Yirrell; citation_author=J Oram; citation_journal_title=Aids; citation_volume=15; citation_number=4; citation_pages=293-299; citation_date=2001; " />
      <meta name="citation_reference" content="citation_title=Infection by different HIV-1 subtypes (B and C) results in a similar immune activation profile despite distinct immune backgrounds.; citation_author=Z Weisman; citation_author=A Kalinkovich; citation_author=G Borkow; citation_author=M Stein; citation_author=Z Greenberg; citation_journal_title=J Acquir Immune Defic Syndr; citation_volume=21; citation_number=5; citation_pages=157-163; citation_date=1999; " />
      <meta name="citation_reference" content="citation_title=Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda.; citation_author=P Kaleebu; citation_author=N French; citation_author=C Mahe; citation_author=D Yirrell; citation_author=C Watera; citation_journal_title=J Infect Dis; citation_volume=185; citation_number=6; citation_pages=1244-1250; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=Human immunodeficiency virus type 1 subtypes differ in disease progression.; citation_author=PJ Kanki; citation_author=DJ Hamel; citation_author=JL Sankale; citation_author=C Hsieh; citation_author=I Thior; citation_journal_title=J Infect Dis; citation_volume=179; citation_number=7; citation_pages=68-73; citation_date=1999; " />
      <meta name="citation_reference" content="citation_title=Subtypes of human immunodeficiency virus type 1 and disease stage among women in Nairobi, Kenya.; citation_author=JR Neilson; citation_author=GC John; citation_author=JK Carr; citation_author=P Lewis; citation_author=JK Kreiss; citation_journal_title=J Virol; citation_volume=73; citation_number=8; citation_pages=4393-4403; citation_date=1999; " />
      <meta name="citation_reference" content="citation_title=The effect of HIV subtype on rapid disease progression in Rakia, Uganda. Abstract 44LB, 13th Conference on Retroviruses and Opportunistic Infections 2006, Denver, Colorado.; citation_author=O Laeyendecker; citation_number=9; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Different rates of disease progression of HIV type 1 infection in Tanzania based on infecting subtype.; citation_author=A Vasan; citation_author=B Renjifo; citation_author=E Hertzmark; citation_author=B Chaplin; citation_author=G Msamanga; citation_journal_title=Clin Infect Dis; citation_volume=42; citation_number=10; citation_pages=843-852; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Central nervous system infections in individuals with HIV-1 infection.; citation_author=A Mamidi; citation_author=JA DeSimone; citation_author=RJ Pomerantz; citation_journal_title=J Neurovirol; citation_volume=8; citation_number=11; citation_pages=158-167; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=Neurological manifestations of acquired immunodeficiency syndrome.; citation_author=JH McArthur; citation_author=JC McArthur; citation_journal_title=J Neurosci Nurs; citation_volume=18; citation_number=12; citation_pages=242-249; citation_date=1986; " />
      <meta name="citation_reference" content="citation_title=Neurological complications of HIV infection.; citation_author=RW Price; citation_journal_title=Lancet; citation_volume=348; citation_number=13; citation_pages=445-452; citation_date=1996; " />
      <meta name="citation_reference" content="citation_title=Temporal trends in the incidence of HIV-1-related neurologic diseases: Multicenter AIDS Cohort Study, 1985–1992.; citation_author=H Bacellar; citation_author=A Munoz; citation_author=EN Miller; citation_author=BA Cohen; citation_author=D Besley; citation_journal_title=Neurology; citation_volume=44; citation_number=14; citation_pages=1892-1900; citation_date=1994; " />
      <meta name="citation_reference" content="citation_title=Pathogenesis of human immunodeficiency virus-induced neurological disease.; citation_author=AV Albright; citation_author=SS Soldan; citation_author=F Gonzalez-Scarano; citation_journal_title=J Neurovirol; citation_volume=9; citation_number=15; citation_pages=222-227; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=Evolving paradigms in the pathogenesis of HIV-1-associated dementia.; citation_author=T Fischer-Smith; citation_author=J Rappaport; citation_journal_title=Expert Rev Mol Med; citation_volume=7; citation_number=16; citation_pages=1-26; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=HIV infection and dementia.; citation_author=S Gartner; citation_journal_title=Science; citation_volume=287; citation_number=17; citation_pages=602-604; citation_date=2000; " />
      <meta name="citation_reference" content="citation_title=The neuropathogenesis of AIDS.; citation_author=F Gonzalez-Scarano; citation_author=J Martin-Garcia; citation_journal_title=Nat Rev Immunol; citation_volume=5; citation_number=18; citation_pages=69-81; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Quantifying HIV-1 RNA using the polymerase chain reaction on cerebrospinal fluid and serum of seropositive individuals with and without neurologic abnormalities.; citation_author=AJ Conrad; citation_author=P Schmid; citation_author=K Syndulko; citation_author=EJ Singer; citation_author=RM Nagra; citation_journal_title=J Acquir Immune Defic Syndr Hum Retrovirol; citation_volume=10; citation_number=19; citation_pages=425-435; citation_date=1995; " />
      <meta name="citation_reference" content="citation_title=Immune response-associated production of neopterin release from macrophages primarily under control of interferon-gamma.; citation_author=C Huber; citation_author=R Batchelor; citation_author=D Fuchs; citation_author=A Hause; citation_author=A Lang; citation_journal_title=J Exp Med; citation_volume=160; citation_number=20; citation_pages=310-316; citation_date=1984; " />
      <meta name="citation_reference" content="citation_title=Predictive markers of AIDS dementia complex: CD4 cell count and cerebrospinal fluid concentrations of beta 2-microglobulin and neopterin.; citation_author=BJ Brew; citation_author=N Dunbar; citation_author=L Pemberton; citation_author=J Kaldor; citation_journal_title=J Infect Dis; citation_volume=174; citation_number=21; citation_pages=294-298; citation_date=1996; " />
      <meta name="citation_reference" content="citation_title=Expansion of neopterin and beta 2-microglobulin in cerebrospinal fluid reaches maximum levels early and late in the course of human immunodeficiency virus infection.; citation_author=JR Bogner; citation_author=B Junge Hulsing; citation_author=U Kronawitter; citation_author=I Sadri; citation_author=A Matuschke; citation_journal_title=Clin Investig; citation_volume=70; citation_number=22; citation_pages=665-669; citation_date=1992; " />
      <meta name="citation_reference" content="citation_title=Neurological evaluation of untreated human immunodeficiency virus infected adults in Ethiopia.; citation_author=DB Clifford; citation_author=MT Mitike; citation_author=Y Mekonnen; citation_author=J Zhang; citation_author=G Zenebe; citation_journal_title=J Neurovirol; citation_volume=13; citation_number=23; citation_pages=67-72; citation_date=2007; " />
      <meta name="citation_reference" content="citation_title=Impact of human immunodeficiency virus (HIV) subtypes on HIV-associated neurological disease.; citation_author=KJ Liner; citation_author=CD Hall; citation_author=KR Robertson; citation_journal_title=J Neurovirol; citation_volume=13; citation_number=24; citation_pages=291-304; citation_date=2007; " />
      <meta name="citation_reference" content="citation_title=Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa.; citation_author=MH Wong; citation_author=K Robertson; citation_author=N Nakasujja; citation_author=R Skolasky; citation_author=S Musisi; citation_journal_title=Neurology; citation_volume=68; citation_number=25; citation_pages=350-355; citation_date=2007; " />
      <meta name="citation_reference" content="citation_title=Neurocognitive consequences of HIV in southern India: a preliminary study of clade C virus.; citation_author=T Yepthomi; citation_author=R Paul; citation_author=S Vallabhaneni; citation_author=N Kumarasamy; citation_author=DF Tate; citation_journal_title=J Int Neuropsychol Soc; citation_volume=12; citation_number=26; citation_pages=424-430; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=HIV-associated cognitive impairment in sub-Saharan Africa–the potential effect of clade diversity.; citation_author=N Sacktor; citation_author=N Nakasujja; citation_author=K Robertson; citation_author=DB Clifford; citation_journal_title=Nat Clin Pract Neurol; citation_volume=3; citation_number=27; citation_pages=436-443; citation_date=2007; " />
      <meta name="citation_reference" content="citation_title=Clinical application of cerebrospinal fluid neopterin concentrations in HIV infection.; citation_author=AL-M Hagberg L; citation_author=S Abdulle; citation_author=M Gisslen; citation_journal_title=Pteridines; citation_number=28; citation_pages=102-106; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Human immunodeficiency virus reverse transcriptase and protease sequence database.; citation_author=RW Shafer; citation_author=DR Jung; citation_author=BJ Betts; citation_author=Y Xi; citation_author=MJ Gonzales; citation_journal_title=Nucleic Acids Res; citation_volume=28; citation_number=29; citation_pages=346-348; citation_date=2000; " />
      <meta name="citation_reference" content="citation_title=Cerebrospinal fluid viral load, intrathecal immunoactivation, and cerebrospinal fluid monocytic cell count in HIV-1 infection.; citation_author=M Gisslén; citation_author=D Fuchs; citation_author=B Svennerholm; citation_author=L Hagberg; citation_journal_title=J Acquir Immune Defic Syndr; citation_volume=21; citation_number=30; citation_pages=271-276; citation_date=1999; " />
      <meta name="citation_reference" content="citation_title=Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment.; citation_author=SS Spudich; citation_author=AC Nilsson; citation_author=ND Lollo; citation_author=TJ Liegler; citation_author=CJ Petropoulos; citation_journal_title=BMC Infect Dis; citation_volume=5; citation_number=31; citation_pages=98; citation_date=2005; " />

  <link rel="canonical" href="http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0001971" />

    <meta name="twitter:card" content="summary"/>
    <meta name="twitter:site" content="@plosone"/>
    <meta name="twitter:title" content="Cerebrospinal Fluid Viral Load and Intrathecal Immune Activation in Individuals Infected with Different HIV-1 Genetic Subtypes"/>
    <meta name="twitter:description" content="BackgroundHIV-1 exhibits a high degree of genetic diversity and is presently divided into 3 distinct HIV-1 genetic groups designated major (M), non-M/non-O (N) and outlier (O). Group M, which currently comprises 9 subtypes (A-D, F-H, J and K), at least 34 circulating recombinant forms (CRFs) and several unique recombinant forms (URFs) is responsible for most of the HIV-1 epidemic. Most of the current knowledge of HIV-1 central nervous system (CNS) infection is based on subtype B. However, subtypes other than subtype B account for the majority of global HIV-1 infections. Therefore, we investigated whether subtypes have any influence on cerebrospinal fluid (CSF) markers of HIV-1 CNS infection.Methodology/Principal FindingsCSF HIV-1 RNA, CSF neopterin and CSF white blood cell (WBC) count were measured in patients infected with different HIV-1 subtypes. Using multivariate regression analysis, no differences in the CSF WBC count, neopterin and viral load were found between various HIV-1 subtypes.ConclusionsWe did not find any subtype-dependent differences in the markers evaluated in this study."/>
      <meta name="twitter:image" content="http://dx.plos.org/10.1371/journal.pone.0001971.g001"/>

  <meta property="og:title" content="Cerebrospinal Fluid Viral Load and Intrathecal Immune Activation in Individuals Infected with Different HIV-1 Genetic Subtypes" />
  <meta property="og:type" content="article" />
  <meta property="og:url" content="http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0001971" />

 <!--end articleInfoX-->

  <link rel="pingback" href="http://www.plosone.org/pingback" />


  <link rel="shortcut icon" href="/images/favicon.ico" type="image/x-icon"/>
  <link rel="home" title="home" href="/"/>
  <link rel="alternate" type="application/rss+xml"
        title="PLOS ONE: New Articles"
        href="http://www.plosone.org/article/feed"/>
</head>
<body>

  <div id="page-wrap">
    <div id="topbanner" class="cf">

<!-- Div for the ad at the top of journal home page-->
<div class="center">
  <div class="title">Advertisement</div>
  <iframe id='a3ac9da4' name='a3ac9da4'
    src='http://ads.plos.org/www/delivery/afr.php?zoneid=345&amp;cb=8751'
    frameborder='0' scrolling='no' width='730' height='90'>
    <a href='http://ads.plos.org/www/delivery/ck.php?n=a3ac9da4&amp;cb=2450'
      target='_top'><img src='http://ads.plos.org/www/delivery/avw.php?zoneid=345&amp;cb=6865&amp;n=a3ac9da4'
      border='0' alt=''/>
    </a>
  </iframe>
</div>    </div>

    <div id="pagehdr-wrap">
      <div id="pagehdr">
        <div id="user" class="nav">
          <ul>
            <li><a href="http://www.plos.org">plos.org</a></li>
            <li><a href="https://register.plos.org/ambra-registration/register.action">create account</a></li>
            <li class="btn-style"><a
              href="/user/secure/secureRedirect.action?goTo=%2Farticle%2FfetchArticle.action%3FarticleURI%3Dinfo%253Adoi%252F10.1371%252Fjournal.pone.0001971">sign in</a>
            </li>
          </ul>
        </div>
        <div class="logo">
          <a href="/"><img src="/images/logo.png" alt="PLOS ONE"></a>
        </div>

<div id="nav-main" class="nav">
  <ul>
        <li id="mn-01"><a href="/taxonomy" class="areas-link">Subject Areas</a></li>
    <li id="mn-02"><a href="javascript:void(0);">For Authors</a>
      <div class="submenu" style="width: 540px; margin-left: -300px;">
        <div class="block">
          <div class="submit-script">
            <h3>Submit your Manuscript</h3>
            <ul>
              <li>Fair, rigorous peer review</li>
              <li>Broad scope and wide reach</li>
            </ul>
            <a href="/static/submissionInstructions" class="btn">get started</a>
          </div>
        </div>
        <div class="menu">
          <ul>
            <li><a href="/static/publish">Why Publish with PLOS ONE</a></li>
            <li><a href="/static/publication">Publication Criteria</a></li>
            <li><a href="/static/editorial">Editorial Policies</a></li>
            <li><a href="/static/guidelines">Preparing A Manuscript</a></li>
            <li><a href="/static/figureGuidelines">Figure and Table Guidelines</a></li>
          <li><a href="/static/supportingInformation">Supporting Information Guidelines</a></li>
            <li><a href="/static/submissionInstructions">Submitting a Manuscript</a></li>
          </ul>
        </div>
      </div>
    </li>

    <li id="mn-03"><a href="javascript:void(0);">About Us</a>
      <div class="submenu" style="width:248px; margin-left:-30px;">
        <div class="menu">
          <ul>
            <li><a href="/static/information">Journal Information</a></li>
            <li><a href="/static/edboard">Editorial Board</a></li>
            <li><a href="/static/reviewerGuidelines">Reviewer Guidelines</a></li>
            <li><a href="/static/almInfo">Article-Level Metrics</a></li>
            <li><a href="/static/license">Open-Access License</a></li>
            <li><a href="/static/downloads">Media Downloads</a></li>
            <li><a href="/static/commentGuidelines">Guidelines for Comments</a></li>
            <li><a href="/static/corrections">Corrections</a></li>
            <li><a href="/static/help">Help Using this Site</a></li>
            <li><a href="/static/contact">Contact Us</a></li>
          </ul>
        </div>
      </div>
    </li>
  </ul>
<div id="db">
  <form name="searchForm" action="/search/simple?noSearchFlag=true&amp;query=&amp;articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0001971" method="get" >
<input type="hidden" name="from" value="globalSimpleSearch" id="from"/><input type="hidden" name="filterJournals" value="PLoSONE" id="filterJournals"/>    <fieldset>
      <legend>Search</legend>
      <label for="search">Search</label>
      <div class="wrap">
        <input id="search" type="text" name="query" placeholder="Search">
        <input type="image" alt="SEARCH" src="/images/icon.search.gif">
      </div>
    </fieldset>
  </form>
    <a id="advSearch" href="/search/advanced?noSearchFlag=true&amp;query=&amp;articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0001971&filterJournals=PLoSONE">advanced search</a>
</div></div>

      </div>
      <!-- pagehdr-->
    </div>
    <!-- pagehdr-wrap -->

  <!--body and html tags gets closed in global_footer.ftl-->
<script type="text/javascript" src="/javascript/mathjax/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>

<div id="pagebdy-wrap">
  <div id="pagebdy">

    <div id="article-block" class="cf">

<div class="article-meta cf">
  <ul id="almSignPost" style="display: none;"></ul>
  <div class="article-type">
    <span class="type oa">Open Access</span>
      <span class="type pr">Peer-Reviewed</span>
  </div>
</div>

<div class="header" id="hdr-article">

<div class="article-kicker">
      <span id="article-type-heading">
        Research Article
      </span>
</div>  <h1 property="dc:title" datatype="" rel="dc:type" href="http://purl.org/dc/dcmitype/Text">
    Cerebrospinal Fluid Viral Load and Intrathecal Immune Activation in Individuals Infected with Different HIV-1 Genetic Subtypes
  </h1>

  <ul class="authors">
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Sahra Abdulle
              <span class="corresponding">mail</span>, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              <p><span class="email">*</span>To whom correspondence should be addressed. E-mail: <a href="mailto:sahra.abdulle@infect.gu.se">sahra.abdulle@infect.gu.se</a></p>

                <p>Affiliation:
                  Department of Infectious Diseases, The Sahlgrenska Academy, Göteborg University, Göteborg, Sweden
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Lars Hagberg, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Department of Infectious Diseases, The Sahlgrenska Academy, Göteborg University, Göteborg, Sweden
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Bo Svennerholm, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Department of Virology, The Sahlgrenska Academy, Göteborg University, Göteborg, Sweden
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Dietmar Fuchs, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Division of Biological Chemistry, Biocentre, Innsbruck Medical University & Ludwig Boltzmann Institute of AIDS Research, Innsbruck, Austria
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Magnus Gisslén
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Department of Infectious Diseases, The Sahlgrenska Academy, Göteborg University, Göteborg, Sweden
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
  </ul>
  <ul class="date-doi-line">
    <li>Published: April 16, 2008</li>
    <li>DOI: 10.1371/journal.pone.0001971</li>
  </ul>


</div><!--end header-->
<div class="main cf" id="pjax-container">
  

<div class="nav items-5" id="nav-article">
  <ul>
  <li>
        <span class="active" name="article">Article</span>
  </li>
  <li>
      <a href="/article/authors/info%3Adoi%2F10.1371%2Fjournal.pone.0001971" name="authors">About the Authors</a>
  </li>
  <li>
      <a href="/article/metrics/info%3Adoi%2F10.1371%2Fjournal.pone.0001971" name="metrics">Metrics</a>
  </li>
  <li>
      <a href="/article/comments/info%3Adoi%2F10.1371%2Fjournal.pone.0001971" name="comments">Comments</a>
  </li>
  <li>
      <a href="/article/related/info%3Adoi%2F10.1371%2Fjournal.pone.0001971" name="related">Related Content</a>
  </li>
  </ul>
</div>

<script type="text/javascript">
  var selected_tab = "article";
</script>
  <div id="figure-thmbs" class="carousel cf">
    <div class="wrapper">
      <div class="slider">
              <div class="item">
                <a href="#pone-0001971-t001" data-doi="info:doi/10.1371/journal.pone.0001971" data-uri="info:doi/10.1371/journal.pone.0001971.t001" title="Table 1">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001971.t001&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001971-g001" data-doi="info:doi/10.1371/journal.pone.0001971" data-uri="info:doi/10.1371/journal.pone.0001971.g001" title="Figure 1">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001971.g001&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
      </div>
    </div>
  </div>

  <div class="nav-col">
    <div class="nav" id="nav-article-page">
      <ul>
        <li class="nav-col-comments"><a href="/article/comments/info%3Adoi%2F10.1371%2Fjournal.pone.0001971">Reader Comments (0)</a></li>
          <li id="nav-figures"><a data-doi="info:doi/10.1371/journal.pone.0001971" >Figures</a></li>
      </ul>
    </div>
  </div>

  <div class="article">







<div class="abstract"><a id="abstract0" name="abstract0" toc="abstract0" title="Abstract"></a><h2>Abstract</h2>
<h3>Background</h3>
<a id="article1.front1.article-meta1.abstract1.sec1.p1" name="article1.front1.article-meta1.abstract1.sec1.p1"></a><p>HIV-1 exhibits a high degree of genetic diversity and is presently divided into 3 distinct HIV-1 genetic groups designated major (M), non-M/non-O (N) and outlier (O). Group M, which currently comprises 9 subtypes (A-D, F-H, J and K), at least 34 circulating recombinant forms (CRFs) and several unique recombinant forms (URFs) is responsible for most of the HIV-1 epidemic. Most of the current knowledge of HIV-1 central nervous system (CNS) infection is based on subtype B. However, subtypes other than subtype B account for the majority of global HIV-1 infections. Therefore, we investigated whether subtypes have any influence on cerebrospinal fluid (CSF) markers of HIV-1 CNS infection.</p>


<h3>Methodology/Principal Findings</h3>
<a id="article1.front1.article-meta1.abstract1.sec2.p1" name="article1.front1.article-meta1.abstract1.sec2.p1"></a><p>CSF HIV-1 RNA, CSF neopterin and CSF white blood cell (WBC) count were measured in patients infected with different HIV-1 subtypes. Using multivariate regression analysis, no differences in the CSF WBC count, neopterin and viral load were found between various HIV-1 subtypes.</p>


<h3>Conclusions</h3>
<a id="article1.front1.article-meta1.abstract1.sec3.p1" name="article1.front1.article-meta1.abstract1.sec3.p1"></a><p>We did not find any subtype-dependent differences in the markers evaluated in this study.</p>

</div>


<div class="articleinfo"><p><strong>Citation: </strong>Abdulle S, Hagberg L, Svennerholm B, Fuchs D, Gisslén M (2008) Cerebrospinal Fluid Viral Load and Intrathecal Immune Activation in Individuals Infected with Different HIV-1 Genetic Subtypes. PLoS ONE 3(4):
          e1971.
            doi:10.1371/journal.pone.0001971</p><p><strong>Editor: </strong>Landon Myer, University of Cape Town, South Africa</p><p><strong>Received:</strong> November 22, 2007; <strong>Accepted:</strong> February 14, 2008; <strong>Published:</strong> April 16, 2008</p><p><strong>Copyright:</strong> © 2008 Abdulle et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p><p><strong>Funding: </strong>This study was supported by grants from the National Institutes of Health (NINDS R01 NS43103-01), the Medical Faculty of Göteborg University (ALFGBG-2874), the Göteborg Medical Society, the Research Foundation of Swedish Physicians Against AIDS and the government of the State of the Austrian Tyrol.</p><p><strong>Competing interests:</strong> The authors have declared that no competing interests exist.</p></div>





<div id="section1" class="section"><a id="s1" name="s1" toc="s1" title="Introduction"></a><h3>Introduction</h3><a id="article1.body1.sec1.p1" name="article1.body1.sec1.p1"></a><p>The genetic diversity of HIV-1 and the biological properties of the different subtypes might be important factors in the pathogenesis, transmissibility and clinical progression of the infection<a href="#pone.0001971-Geretti1">[1]</a>. Some studies have reported that HIV-1 subtype has no significant impact on disease progression <a href="#pone.0001971-Alaeus1">[2]</a>–<a href="#pone.0001971-Weisman1">[5]</a>, while others have provided evidence that differences might exist <a href="#pone.0001971-Kaleebu2">[6]</a>–<a href="#pone.0001971-Neilson1">[8]</a>. For instance subtype D has been suggested to have greater virulence than subtype A <a href="#pone.0001971-Laeyendecker1">[9]</a>, <a href="#pone.0001971-Vasan1">[10]</a></p>
<a id="article1.body1.sec1.p2" name="article1.body1.sec1.p2"></a><p>HIV-1 infection is characterized by a spectrum of neurological complications throughout its course, occurring either as a direct consequence of the HIV-1 infection itself or due to opportunistic infections and/or tumours <a href="#pone.0001971-Mamidi1">[11]</a>–<a href="#pone.0001971-Price1">[13]</a>. AIDS Dementia Complex (ADC), the most severe manifestation of HIV-1 central nervous system (CNS) infection, developed in approximately 20 % of patients with advanced HIV-1 infection before the widespread use of antiretroviral treatment<a href="#pone.0001971-Bacellar1">[14]</a>. ADC is considered the result of a complex interplay between the effects of viral replication and immune activation in the brain, which ultimately lead to neuronal injury and death <a href="#pone.0001971-Albright1">[15]</a>–<a href="#pone.0001971-GonzalezScarano1">[18]</a>.</p>
<a id="article1.body1.sec1.p3" name="article1.body1.sec1.p3"></a><p>Cerebrospinal fluid (CSF) HIV-1 RNA and neopterin are two of the most extensively studied surrogate markers of HIV-1 CNS infection. HIV-1 RNA can be detected in the CSF of virtually all untreated patients irrespective of disease stage <a href="#pone.0001971-Conrad1">[19]</a>. Neopterin is a marker of cell-mediated immune activation produced by cells of the macrophage lineage upon stimulation by interferon-γ <a href="#pone.0001971-Huber1">[20]</a>. Increased CSF neopterin concentrations are found in HIV-1-infected patients with AIDS, ADC <a href="#pone.0001971-Brew1">[21]</a> or with opportunistic CNS infections, but moderately elevated levels are also frequently found in asymptomatic HIV-1-infected individuals <a href="#pone.0001971-Bogner1">[22]</a>.</p>
<a id="article1.body1.sec1.p4" name="article1.body1.sec1.p4"></a><p>There is very sparse information available on the role of different subtypes in HIV-1 infection of the CNS. Even though the majority of HIV-1 infections in the world are caused by other subtypes, our knowledge of HIV-1 related neurological disease is based mainly on subtype B. Moreover, the extent of HIV-1 induced neurocognitive impairment in regions where HIV-1 is highly prevalent remains largely unknown, although some recent studies have begun to address this issue<a href="#pone.0001971-Clifford1">[23]</a>–<a href="#pone.0001971-Yepthomi1">[26]</a>. These studies have shown varying results<a href="#pone.0001971-Sacktor1">[27]</a>. For instance, an Ugandan study showed an ADC prevalence of 31% in HIV-1 infected patients <a href="#pone.0001971-Wong1">[25]</a>, while a blinded study of HIV-1 positive and negative Ethiopian subjects found no significant differences between the two groups<a href="#pone.0001971-Clifford1">[23]</a>. Since Ugandan patients are predominantly infected with subtype D and Ethiopians with subtype C, this finding dictates further investigation into the role of subtype in HIV-1 CNS infection <a href="#pone.0001971-Sacktor1">[27]</a>. Subtype differences in co-receptor usage, disease progression rate as well viral diversity could predispose for differences in the propensity for neurological disease<a href="#pone.0001971-Liner1">[24]</a> .</p>
<a id="article1.body1.sec1.p5" name="article1.body1.sec1.p5"></a><p>The aim of this study was to determine whether subtype has any influence on CSF markers of infectious activity.</p>
</div>

<div id="section2" class="section"><a id="s2" name="s2" toc="s2" title="Materials and Methods"></a><h3>Materials and Methods</h3>
<h4>Participants</h4>
<a id="article1.body1.sec2.sec1.p1" name="article1.body1.sec2.sec1.p1"></a><p>Archived data from 128 neurologically asymptomatic HIV-1 infected patients who underwent lumbar punctures in a prospective research cohort at the Department of Infectious Diseases, Sahlgrenska University Hospital, Göteborg, Sweden were included. The CSF was handled, analysed and stored immediately after collection according to protocol. Patients were specifically queried regarding neurological problems and clinically examined. The patients were either treatment naïve (n = 124) or had been off treatment for at least 6 months (n = 4). Demographics and clinical characteristics of the study participants are presented in <a href="#pone-0001971-t001">Table 1</a>.</p>
<div class="figure" id="pone-0001971-t001"><div class="img"><a name="pone-0001971-t001" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001971.t001&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001971" data-uri="info:doi/10.1371/journal.pone.0001971.t001"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001971.t001&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001971.t001/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001971.t001/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001971.t001/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001971.t001/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001971.t001.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001971.t001/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001971.t001/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001971.t001.TIF"></span>)
                </a></li></ul></div><p><strong>Table 1.  <span>Demographic and clinical characteristics of the study patients.</span></strong></p><span>doi:10.1371/journal.pone.0001971.t001</span></div>

<h4>Laboratory methods</h4>
<a id="article1.body1.sec2.sec2.p1" name="article1.body1.sec2.sec2.p1"></a><p>HIV-1 RNA was quantified in cell-free CSF and plasma using the Roche Amplicor Monitor assay (version 1.0 and 1.5, Hoffman La-Roche, Basel, Switzerland). Neopterin was measured in CSF and serum using a commercially available radio-immunoassay (Henningtest Neopterin, BRAHMS, Berlin, Germany). The normal reference value for neopterin was ≤5.8 nmol/L in CSF and ≤8.8 nmol/l in serum <a href="#pone.0001971-HagbergL1">[28]</a>. Routine assessments also included CSF white blood cell (WBC) counts and peripheral blood CD4 cell count determinations.</p>
<a id="article1.body1.sec2.sec2.p2" name="article1.body1.sec2.sec2.p2"></a><p>Subtypes were identified by the Stanford HIV Reverse Transcriptase (RT) and Protease (PR) Sequence Database (<a href="http://hivdb.stanford.edu">http://hivdb.stanford.edu</a>) <a href="#pone.0001971-Shafer1">[29]</a> using consensus RT and PR sequences obtained through an in-house method. Plasma HIV-1 RNA was extracted using the Magnapure Total Nucleic Acid isolation kit (Roche) according to the manufacturer’s protocol. The outer primers RT1 (<span class="gene">5′-CTGTACCAGTAAAATTAAA-GCCA-3′</span>), RT2 (<span class="gene">5′-TATGTCATTGACAGTCCAGCT -3′</span>), PR1 (<span class="gene">5′- CCGATAGACAAGGAACT -3′</span>) and PR2 (<span class="gene">5′- TCTACTAATGCTTTTATTTTT -3′</span>) were used in the first round polymerase chain reaction (PCR). The reaction mixture contained 8 units RNasin® (Promega), 4 units AMV (Promega), 200 mM of each dNTP (Roche), 1 unit AmpliTAQ DNA polymerase (ABI), anti-TAQ as recommended by the manufacturer (Clontech), 200 nM of the each of the outer primers, 60 mM KCl, and 2.0 mM MgCl2 in 20 mM Tris-HCl buffer. The amplification program in the first PCR cycle was 60 min at 43°C then 2 min 30s at 94°C followed by 40 cycles with settings 20 s at 94°C, 20 s at 50°C, and 60 s at 72°C. The final cycle was 5 min at 72°C and a final incubation at 8°C.</p>
<a id="article1.body1.sec2.sec2.p3" name="article1.body1.sec2.sec2.p3"></a><p>The next step was a second (nested) PCR with a mixture consisting of 5 µl of the first PCR product and the same reagents as in the first PCR excluding RNasin® and AMV, and the inner primers RT3 (5′- ATGGCCATTGACAGAAGAAA3′), RT4 (<span class="gene">5′- AGGCTGTACTGTCCATTTAT-3′</span>), PR 3 (<span class="gene">5′- ACTTCCCTCAGATCACTCTT-3′</span>) and PR 4 (<span class="gene">5′- TTCCTGGCTTTAATTTTACT- 3′</span>). The amplification steps in the nested PCR were the same as in the first PCR except for the omission of the first step of 60s at 43°C. All PCR reactions were carried out in GenAmp® PCR system 9600 (ABI).</p>
<a id="article1.body1.sec2.sec2.p4" name="article1.body1.sec2.sec2.p4"></a><p>The nested PCR product was separated by agarose gel electrophoresis of 15 µl of the master mix on 1.8 % agarose, containing 0.25 µg ethidium bromide per ml, and visualized by UV illumination.</p>
<a id="article1.body1.sec2.sec2.p5" name="article1.body1.sec2.sec2.p5"></a><p>The PCR product was purified using QIAquick PCR Purification Kit (Qiagen) prior to cycle sequencing with Big Dye Terminator Ready Reaction Kit version 1.1 (ABI Prism).</p>
<a id="article1.body1.sec2.sec2.p6" name="article1.body1.sec2.sec2.p6"></a><p>Nucleotide sequences were analyzed on the ABI Prism 3100 Genetic Analyzer sequencer and aligned with Sequence Navigator software.</p>


<h4>Statistical analysis</h4>
<a id="article1.body1.sec2.sec3.p1" name="article1.body1.sec2.sec3.p1"></a><p>Plasma and CSF HIV-1 RNA were log<sub>10</sub> transformed before statistical analysis. Because of the skewed distributions of several of the study variables, median and interquartile range (IQR; 25th -75th percentile) were used for descriptive statistics. Mann-Whitney’s (two independent samples) and Kruskall Wallis (several independent samples) tests were used for comparisons. Spearman’s rank correlation coefficient was used for evaluation of correlations. Linear multiple regression was performed on the CSF markers to evaluate the effect of different subtypes. CSF neopterin was log transformed for the multivariate analysis. Four outliers were removed from the CSF WBC count before the multivariate analysis. The removal of outliers was the best way to transform the CSF WBC count data and was done by a statistician. A P-value of &lt;0.05 was considered significant.</p>

</div>

<div id="section3" class="section"><a id="s3" name="s3" toc="s3" title="Results"></a><h3>Results</h3><a id="article1.body1.sec3.p1" name="article1.body1.sec3.p1"></a><p>Subtype was successfully assigned in both the RT and protease sequences in all but six samples that could be identified only by protease (2B, 2A, and 1CRF01_AE) or by RT (1CRF01_AE) sequence analysis. <a href="#pone-0001971-g001">Figure 1</a> shows the results of the descriptive statistics for HIV-1 RNA and neopterin in CSF and plasma/serum, the CSF WBC count, the CSF/blood HIV-1 RNA and neopterin quotients and the CD4 cell count. All but four patients had elevated CSF neopterin concentrations. The median CSF neopterin levels (Panel A) were highest in patients with subtypes B and C but this difference did not reach statistical significance. Seven out of the 128 patients (5%) had CSF HIV-1 RNA below the detection limit of 50 copies/ml. Panel B and D show the CSF HIV-1 RNA and the CSF/plasma HIV-1 RNA quotients with median values that were in the same range in all the subtypes. The median CSF/serum neopterin quotients in panel C were higher in subtypes C and D although this difference was not significant. Most of the patients with subtype C and half of those with subtype D had significantly higher neopterin levels in CSF than in serum, which would explain the higher CSF/serum neopterin quotients. This was independent of disease stage.</p>
<div class="figure" id="pone-0001971-g001"><div class="img"><a name="pone-0001971-g001" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001971.g001&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001971" data-uri="info:doi/10.1371/journal.pone.0001971.g001"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001971.g001&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001971.g001/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001971.g001/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001971.g001/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001971.g001/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001971.g001.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001971.g001/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001971.g001/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001971.g001.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 1.  <span>Boxplots of the cerebrospinal fluid (CSF) and plasma/serum levels of HIV-1 RNA and neopterin, the CSF/P-RNA and CSF/S-neopterin quotients, the CD4+ T- lymphocyte and the CSF white blood cell (WBC) counts according to subtype.</span></strong></p><a id="article1.body1.sec3.fig1.caption1.p1" name="article1.body1.sec3.fig1.caption1.p1"></a><p>The number of available samples is shown by n. The P-values on the top right of each panel are calculated using Kruskall-Wallis test. The bar inside the box shows the median values, the bottom and top hinges of the box represent the 25th and 75th percentile. The dotted lines represent the normal reference values. Outliers are depicted by o, extremes by *. Circulating recombinant forms CRF01_AE and CRF02_AG are designated as AE and AG.</p>
<span>doi:10.1371/journal.pone.0001971.g001</span></div><a id="article1.body1.sec3.p2" name="article1.body1.sec3.p2"></a><p>A significant subtype dependent difference was found in the CSF WBC count (p&lt;0.05) in the Kruskall Wallis test (Panel E). A statistically significant difference in the CSF WBC count was found between subtype B and subtype C (p&lt;0.05) when comparing individual subtypes. However, subtype did not prove to be a significant independent predictor for any of the CSF markers in the multiple regression analysis when all the other CSF markers, CD4+ T- cell count, plasma viral load, serum neopterin, patient origin, age and sex along with subtype were included as independent variables (data not shown). The CD4 cell count, CSF and plasma HIV-1 RNA were significant independent predictors of CSF WBC count. Patients with subtype D had the lowest CD4 cell counts (Panel F) while those carrying the subtype CRF01_AE had the highest serum neopterin concentrations (Panel G). The median Plasma HIV-1 RNA levels (Panel H) were in the same range throughout the subtypes. A subtype-independent analysis showed a significant correlation between CSF HIV-1 RNA and CSF neopterin (r<sub>s</sub> = 0.45, p&lt;0.0001).</p>
</div>

<div id="section4" class="section"><a id="s4" name="s4" toc="s4" title="Discussion"></a><h3>Discussion</h3><a id="article1.body1.sec4.p1" name="article1.body1.sec4.p1"></a><p>We did not find any significant subtype-specific differences in the neuromarkers investigated in this study. CSF HIV-1 RNA and neopterin are two of the most studied markers of HIV-1 CNS infection. These markers reflect processes implicated in the pathogenesis of HIV-1 infection of the CNS, which makes them appropriate to study. Although the number of subjects studied was relatively low, especially for subtypes other than B and C, there are no larger CSF studies published on HIV-1 subtypes and CSF markers of infectious activity. The number of patients without antiretroviral treatment included would be sufficient to detect any larger differences between subtypes. Minor differences are of course not possible to detect.</p>
<a id="article1.body1.sec4.p2" name="article1.body1.sec4.p2"></a><p>We found a statistically significant difference in the CSF WBC count between subtypes B and C in the univariate analysis where subjects with subtype C had more CSF cells than those with subtype B. This result could not be verified in the multivariate analysis when all other independent variables were taken into account. Subtype B included more patients with advanced disease compared to subtype C, which probably explains this difference.</p>
<a id="article1.body1.sec4.p3" name="article1.body1.sec4.p3"></a><p>A slightly increased CSF WBC count that wanes in advanced systemic infection is a frequent finding in HIV-1 infected patients with or without symptoms <a href="#pone.0001971-Gissln1">[30]</a>, <a href="#pone.0001971-Spudich1">[31]</a>. In a subtype-independent analysis, patients with CD4 &lt;50 had significantly less CSF pleocytosis (data not shown) than those with more preserved CD4 cell counts, which is in agreement with previous studies. The CSF pleocytosis was correlated to the CSF viral load and inversely correlated to the plasma viral load, which also is in agreement with previous findings <a href="#pone.0001971-Gissln1">[30]</a>, <a href="#pone.0001971-Spudich1">[31]</a>.</p>
<a id="article1.body1.sec4.p4" name="article1.body1.sec4.p4"></a><p>A limitation in the study is that no patients with ADC were included, mirroring the fact, that ADC is nowadays uncommon in areas with access to antiretroviral treatment. Another limitation is that disease duration was unknown in a majority of cases. A longitudinal prospective study design would have been preferable to identify differences. These days, studies of this kind are not possible to conduct due to treatment intervention.</p>
<a id="article1.body1.sec4.p5" name="article1.body1.sec4.p5"></a><p>There were more patients who had suffered an AIDS defining illness in the subtype B group compared to the other groups which in its turn is explained by the change in the epidemiology of HIV-1 infection in Sweden and most of Europe: in the Pre-HAART era the majority of patients were of European origin, carrying subtype B. In the HAART-era, new infections are mostly diagnosed in individuals who acquired their infection in other parts of the world where other subtypes are predominant. Differences in origin and gender between subjects with different subtypes were taken into account in the multivariate analysis.</p>
<a id="article1.body1.sec4.p6" name="article1.body1.sec4.p6"></a><p>If subtype has little impact on susceptibility to CNS HIV-1 infection, which factors are then important? Host factors, coexisting morbidities and co-infections in combination with viral virulence factors might be more important than subtype. As yet, the role of these factors has been very little studied. Why some patients suffer from high CSF viral loads and/or signs of intrathecal immune activation while others exhibit only minor signs of CNS infectious activity remains unknown.</p>

<h4>Conclusions</h4>
<a id="article1.body1.sec4.sec1.p1" name="article1.body1.sec4.sec1.p1"></a><p>We did not find any differences in CSF biomarkers of CNS infectious activity between subtypes in neurologically asymptomatic, untreated HIV-1 infected individuals.</p>

</div>



<div class="contributions"><a id="authcontrib" name="authcontrib" toc="authcontrib" title="Author Contributions"></a><h3>Author Contributions</h3><p>Contributed to the conception of the study, data interpretation, and the writing of the paper: MG LH SA. Performed the neopterin analysis and assisted in drafting the manuscript: DF. Conducted the subtyping and helped in drafting the manuscript: BS.</p></div><div><a id="references" name="references" toc="references" title="References"></a><h3>References</h3><ol class="references"><li><span class="label">1.
              </span><a name="pone.0001971-Geretti1" id="pone.0001971-Geretti1"></a>Geretti AM (2006) HIV-1 subtypes: epidemiology and significance for HIV management. Curr Opin Infect Dis  19: 1–7.  <ul class="find" data-citedArticleID="1089502" data-doi="10.1097/01.qco.0000200293.45532.68"><li><a href="http://dx.doi.org/10.1097/01.qco.0000200293.45532.68" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=HIV-1+subtypes%3A+epidemiology+and+significance+for+HIV+management." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22HIV-1+subtypes%3A+epidemiology+and+significance+for+HIV+management.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">2.
              </span><a name="pone.0001971-Alaeus1" id="pone.0001971-Alaeus1"></a>Alaeus A, Lidman K, Bjorkman A, Giesecke J, Albert J (1999) Similar rate of disease progression among individuals infected with HIV-1 genetic subtypes A-D. Aids  13: 901–907.  <ul class="find" data-citedArticleID="1089482" data-doi="10.1097/00002030-199905280-00005"><li><a href="http://dx.doi.org/10.1097/00002030-199905280-00005" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Similar+rate+of+disease+progression+among+individuals+infected+with+HIV-1+genetic+subtypes+A-D." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Similar+rate+of+disease+progression+among+individuals+infected+with+HIV-1+genetic+subtypes+A-D.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">3.
              </span><a name="pone.0001971-Amornkul1" id="pone.0001971-Amornkul1"></a>Amornkul PN, Tansuphasawadikul S, Limpakarnjanarat K, Likanonsakul S, Young N, et al.  (1999) Clinical disease associated with HIV-1 subtype B' and E infection among 2104 patients in Thailand. Aids  13: 1963–1969.  <ul class="find" data-citedArticleID="1089486" data-doi="10.1097/00002030-199910010-00020"><li><a href="http://dx.doi.org/10.1097/00002030-199910010-00020" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Clinical+disease+associated+with+HIV-1+subtype+B%27+and+E+infection+among+2104+patients+in+Thailand." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Clinical+disease+associated+with+HIV-1+subtype+B%27+and+E+infection+among+2104+patients+in+Thailand.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">4.
              </span><a name="pone.0001971-Kaleebu1" id="pone.0001971-Kaleebu1"></a>Kaleebu P, Ross A, Morgan D, Yirrell D, Oram J, et al.  (2001) Relationship between HIV-1 Env subtypes A and D and disease progression in a rural Ugandan cohort. Aids  15: 293–299.  <ul class="find" data-citedArticleID="1089512" data-doi="10.1097/00002030-200102160-00001"><li><a href="http://dx.doi.org/10.1097/00002030-200102160-00001" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Relationship+between+HIV-1+Env+subtypes+A+and+D+and+disease+progression+in+a+rural+Ugandan+cohort." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Relationship+between+HIV-1+Env+subtypes+A+and+D+and+disease+progression+in+a+rural+Ugandan+cohort.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">5.
              </span><a name="pone.0001971-Weisman1" id="pone.0001971-Weisman1"></a>Weisman Z, Kalinkovich A, Borkow G, Stein M, Greenberg Z, et al.  (1999) Infection by different HIV-1 subtypes (B and C) results in a similar immune activation profile despite distinct immune backgrounds. J Acquir Immune Defic Syndr  21: 157–163.  <ul class="find" data-citedArticleID="1089538"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Infection+by+different+HIV-1+subtypes+%28B+and+C%29+results+in+a+similar+immune+activation+profile+despite+distinct+immune+backgrounds.&amp;auth=&amp;atitle=Infection+by+different+HIV-1+subtypes+%28B+and+C%29+results+in+a+similar+immune+activation+profile+despite+distinct+immune+backgrounds." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Infection+by+different+HIV-1+subtypes+%28B+and+C%29+results+in+a+similar+immune+activation+profile+despite+distinct+immune+backgrounds." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Infection+by+different+HIV-1+subtypes+%28B+and+C%29+results+in+a+similar+immune+activation+profile+despite+distinct+immune+backgrounds.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">6.
              </span><a name="pone.0001971-Kaleebu2" id="pone.0001971-Kaleebu2"></a>Kaleebu P, French N, Mahe C, Yirrell D, Watera C, et al.  (2002) Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda. J Infect Dis  185: 1244–1250.  <ul class="find" data-citedArticleID="1089514" data-doi="10.1086/340130"><li><a href="http://dx.doi.org/10.1086/340130" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Effect+of+human+immunodeficiency+virus+%28HIV%29+type+1+envelope+subtypes+A+and+D+on+disease+progression+in+a+large+cohort+of+HIV-1-positive+persons+in+Uganda." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Effect+of+human+immunodeficiency+virus+%28HIV%29+type+1+envelope+subtypes+A+and+D+on+disease+progression+in+a+large+cohort+of+HIV-1-positive+persons+in+Uganda.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">7.
              </span><a name="pone.0001971-Kanki1" id="pone.0001971-Kanki1"></a>Kanki PJ, Hamel DJ, Sankale JL, Hsieh C, Thior I, et al.  (1999) Human immunodeficiency virus type 1 subtypes differ in disease progression. J Infect Dis  179: 68–73.  <ul class="find" data-citedArticleID="1089516" data-doi="10.1086/314557"><li><a href="http://dx.doi.org/10.1086/314557" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Human+immunodeficiency+virus+type+1+subtypes+differ+in+disease+progression." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Human+immunodeficiency+virus+type+1+subtypes+differ+in+disease+progression.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">8.
              </span><a name="pone.0001971-Neilson1" id="pone.0001971-Neilson1"></a>Neilson JR, John GC, Carr JK, Lewis P, Kreiss JK, et al.  (1999) Subtypes of human immunodeficiency virus type 1 and disease stage among women in Nairobi, Kenya. J Virol  73: 4393–4403.  <ul class="find" data-citedArticleID="1089526"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Subtypes+of+human+immunodeficiency+virus+type+1+and+disease+stage+among+women+in+Nairobi%2C+Kenya.&amp;auth=&amp;atitle=Subtypes+of+human+immunodeficiency+virus+type+1+and+disease+stage+among+women+in+Nairobi%2C+Kenya." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Subtypes+of+human+immunodeficiency+virus+type+1+and+disease+stage+among+women+in+Nairobi%2C+Kenya." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Subtypes+of+human+immunodeficiency+virus+type+1+and+disease+stage+among+women+in+Nairobi%2C+Kenya.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">9.
              </span><a name="pone.0001971-Laeyendecker1" id="pone.0001971-Laeyendecker1"></a>Laeyendecker O, et al.  (2006) The effect of HIV subtype on rapid disease progression in Rakia, Uganda. Abstract 44LB, 13th Conference on Retroviruses and Opportunistic Infections 2006, Denver, Colorado.  <ul class="find" data-citedArticleID="1089518"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=The+effect+of+HIV+subtype+on+rapid+disease+progression+in+Rakia%2C+Uganda.+Abstract+44LB%2C+13th+Conference+on+Retroviruses+and+Opportunistic+Infections+2006%2C+Denver%2C+Colorado.&amp;auth=&amp;atitle=The+effect+of+HIV+subtype+on+rapid+disease+progression+in+Rakia%2C+Uganda.+Abstract+44LB%2C+13th+Conference+on+Retroviruses+and+Opportunistic+Infections+2006%2C+Denver%2C+Colorado." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=The+effect+of+HIV+subtype+on+rapid+disease+progression+in+Rakia%2C+Uganda.+Abstract+44LB%2C+13th+Conference+on+Retroviruses+and+Opportunistic+Infections+2006%2C+Denver%2C+Colorado." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22The+effect+of+HIV+subtype+on+rapid+disease+progression+in+Rakia%2C+Uganda.+Abstract+44LB%2C+13th+Conference+on+Retroviruses+and+Opportunistic+Infections+2006%2C+Denver%2C+Colorado.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">10.
              </span><a name="pone.0001971-Vasan1" id="pone.0001971-Vasan1"></a>Vasan A, Renjifo B, Hertzmark E, Chaplin B, Msamanga G, et al.  (2006) Different rates of disease progression of HIV type 1 infection in Tanzania based on infecting subtype. Clin Infect Dis  42: 843–852.  <ul class="find" data-citedArticleID="1089536" data-doi="10.1086/499952"><li><a href="http://dx.doi.org/10.1086/499952" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Different+rates+of+disease+progression+of+HIV+type+1+infection+in+Tanzania+based+on+infecting+subtype." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Different+rates+of+disease+progression+of+HIV+type+1+infection+in+Tanzania+based+on+infecting+subtype.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">11.
              </span><a name="pone.0001971-Mamidi1" id="pone.0001971-Mamidi1"></a>Mamidi A, DeSimone JA, Pomerantz RJ (2002) Central nervous system infections in individuals with HIV-1 infection. J Neurovirol  8: 158–167.  <ul class="find" data-citedArticleID="1089522" data-doi="10.1080/13550280290049723"><li><a href="http://dx.doi.org/10.1080/13550280290049723" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Central+nervous+system+infections+in+individuals+with+HIV-1+infection." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Central+nervous+system+infections+in+individuals+with+HIV-1+infection.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">12.
              </span><a name="pone.0001971-McArthur1" id="pone.0001971-McArthur1"></a>McArthur JH, McArthur JC (1986) Neurological manifestations of acquired immunodeficiency syndrome. J Neurosci Nurs  18: 242–249.  <ul class="find" data-citedArticleID="1089524" data-doi="10.1097/01376517-198610000-00002"><li><a href="http://dx.doi.org/10.1097/01376517-198610000-00002" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Neurological+manifestations+of+acquired+immunodeficiency+syndrome." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Neurological+manifestations+of+acquired+immunodeficiency+syndrome.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">13.
              </span><a name="pone.0001971-Price1" id="pone.0001971-Price1"></a>Price RW (1996) Neurological complications of HIV infection. Lancet  348: 445–452.  <ul class="find" data-citedArticleID="1089528" data-doi="10.1016/s0140-6736(95)11035-6"><li><a href="http://dx.doi.org/10.1016/s0140-6736(95)11035-6" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Neurological+complications+of+HIV+infection." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Neurological+complications+of+HIV+infection.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">14.
              </span><a name="pone.0001971-Bacellar1" id="pone.0001971-Bacellar1"></a>Bacellar H, Munoz A, Miller EN, Cohen BA, Besley D, et al.  (1994) Temporal trends in the incidence of HIV-1-related neurologic diseases: Multicenter AIDS Cohort Study, 1985–1992. Neurology  44: 1892–1900.  <ul class="find" data-citedArticleID="1089488" data-doi="10.1212/wnl.44.10.1892"><li><a href="http://dx.doi.org/10.1212/wnl.44.10.1892" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Temporal+trends+in+the+incidence+of+HIV-1-related+neurologic+diseases%3A+Multicenter+AIDS+Cohort+Study%2C+1985%E2%80%931992." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Temporal+trends+in+the+incidence+of+HIV-1-related+neurologic+diseases%3A+Multicenter+AIDS+Cohort+Study%2C+1985%E2%80%931992.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">15.
              </span><a name="pone.0001971-Albright1" id="pone.0001971-Albright1"></a>Albright AV, Soldan SS, Gonzalez-Scarano F (2003) Pathogenesis of human immunodeficiency virus-induced neurological disease. J Neurovirol  9: 222–227.  <ul class="find" data-citedArticleID="1089484" data-doi="10.1080/13550280390194073"><li><a href="http://dx.doi.org/10.1080/13550280390194073" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Pathogenesis+of+human+immunodeficiency+virus-induced+neurological+disease." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Pathogenesis+of+human+immunodeficiency+virus-induced+neurological+disease.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">16.
              </span><a name="pone.0001971-FischerSmith1" id="pone.0001971-FischerSmith1"></a>Fischer-Smith T, Rappaport J (2005) Evolving paradigms in the pathogenesis of HIV-1-associated dementia. Expert Rev Mol Med  7: 1–26.  <ul class="find" data-citedArticleID="1089498" data-doi="10.1017/s1462399405010239"><li><a href="http://dx.doi.org/10.1017/s1462399405010239" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Evolving+paradigms+in+the+pathogenesis+of+HIV-1-associated+dementia." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Evolving+paradigms+in+the+pathogenesis+of+HIV-1-associated+dementia.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">17.
              </span><a name="pone.0001971-Gartner1" id="pone.0001971-Gartner1"></a>Gartner S (2000) HIV infection and dementia. Science  287: 602–604.  <ul class="find" data-citedArticleID="1089500" data-doi="10.1126/science.287.5453.602"><li><a href="http://dx.doi.org/10.1126/science.287.5453.602" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=HIV+infection+and+dementia." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22HIV+infection+and+dementia.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">18.
              </span><a name="pone.0001971-GonzalezScarano1" id="pone.0001971-GonzalezScarano1"></a>Gonzalez-Scarano F, Martin-Garcia J (2005) The neuropathogenesis of AIDS. Nat Rev Immunol  5: 69–81.  <ul class="find" data-citedArticleID="1089506" data-doi="10.1038/nri1527"><li><a href="http://dx.doi.org/10.1038/nri1527" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=The+neuropathogenesis+of+AIDS." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22The+neuropathogenesis+of+AIDS.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">19.
              </span><a name="pone.0001971-Conrad1" id="pone.0001971-Conrad1"></a>Conrad AJ, Schmid P, Syndulko K, Singer EJ, Nagra RM, et al.  (1995) Quantifying HIV-1 RNA using the polymerase chain reaction on cerebrospinal fluid and serum of seropositive individuals with and without neurologic abnormalities. J Acquir Immune Defic Syndr Hum Retrovirol  10: 425–435.  <ul class="find" data-citedArticleID="1089496" data-doi="10.1097/00042560-199512000-00005"><li><a href="http://dx.doi.org/10.1097/00042560-199512000-00005" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Quantifying+HIV-1+RNA+using+the+polymerase+chain+reaction+on+cerebrospinal+fluid+and+serum+of+seropositive+individuals+with+and+without+neurologic+abnormalities." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Quantifying+HIV-1+RNA+using+the+polymerase+chain+reaction+on+cerebrospinal+fluid+and+serum+of+seropositive+individuals+with+and+without+neurologic+abnormalities.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">20.
              </span><a name="pone.0001971-Huber1" id="pone.0001971-Huber1"></a>Huber C, Batchelor R, Fuchs D, Hause A, Lang A, et al.  (1984) Immune response-associated production of neopterin release from macrophages primarily under control of interferon-gamma. J Exp Med  160: 310–316.  <ul class="find" data-citedArticleID="1089510" data-doi="10.1084/jem.160.1.310"><li><a href="http://dx.doi.org/10.1084/jem.160.1.310" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Immune+response-associated+production+of+neopterin+release+from+macrophages+primarily+under+control+of+interferon-gamma." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Immune+response-associated+production+of+neopterin+release+from+macrophages+primarily+under+control+of+interferon-gamma.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">21.
              </span><a name="pone.0001971-Brew1" id="pone.0001971-Brew1"></a>Brew BJ, Dunbar N, Pemberton L, Kaldor J (1996) Predictive markers of AIDS dementia complex: CD4 cell count and cerebrospinal fluid concentrations of beta 2-microglobulin and neopterin. J Infect Dis  174: 294–298.  <ul class="find" data-citedArticleID="1089492" data-doi="10.1093/infdis/174.2.294"><li><a href="http://dx.doi.org/10.1093/infdis/174.2.294" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Predictive+markers+of+AIDS+dementia+complex%3A+CD4+cell+count+and+cerebrospinal+fluid+concentrations+of+beta+2-microglobulin+and+neopterin." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Predictive+markers+of+AIDS+dementia+complex%3A+CD4+cell+count+and+cerebrospinal+fluid+concentrations+of+beta+2-microglobulin+and+neopterin.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">22.
              </span><a name="pone.0001971-Bogner1" id="pone.0001971-Bogner1"></a>Bogner JR, Junge Hulsing B, Kronawitter U, Sadri I, Matuschke A, et al.  (1992) Expansion of neopterin and beta 2-microglobulin in cerebrospinal fluid reaches maximum levels early and late in the course of human immunodeficiency virus infection. Clin Investig  70: 665–669.  <ul class="find" data-citedArticleID="1089490" data-doi="10.1007/bf00180282"><li><a href="http://dx.doi.org/10.1007/bf00180282" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Expansion+of+neopterin+and+beta+2-microglobulin+in+cerebrospinal+fluid+reaches+maximum+levels+early+and+late+in+the+course+of+human+immunodeficiency+virus+infection." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Expansion+of+neopterin+and+beta+2-microglobulin+in+cerebrospinal+fluid+reaches+maximum+levels+early+and+late+in+the+course+of+human+immunodeficiency+virus+infection.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">23.
              </span><a name="pone.0001971-Clifford1" id="pone.0001971-Clifford1"></a>Clifford DB, Mitike MT, Mekonnen Y, Zhang J, Zenebe G, et al.  (2007) Neurological evaluation of untreated human immunodeficiency virus infected adults in Ethiopia. J Neurovirol  13: 67–72.  <ul class="find" data-citedArticleID="1089494" data-doi="10.1080/13550280601169837"><li><a href="http://dx.doi.org/10.1080/13550280601169837" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Neurological+evaluation+of+untreated+human+immunodeficiency+virus+infected+adults+in+Ethiopia." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Neurological+evaluation+of+untreated+human+immunodeficiency+virus+infected+adults+in+Ethiopia.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">24.
              </span><a name="pone.0001971-Liner1" id="pone.0001971-Liner1"></a>Liner KJ 2nd, Hall CD, Robertson KR (2007) Impact of human immunodeficiency virus (HIV) subtypes on HIV-associated neurological disease. J Neurovirol  13: 291–304.  <ul class="find" data-citedArticleID="1089520" data-doi="10.1080/13550280701422383"><li><a href="http://dx.doi.org/10.1080/13550280701422383" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Impact+of+human+immunodeficiency+virus+%28HIV%29+subtypes+on+HIV-associated+neurological+disease." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Impact+of+human+immunodeficiency+virus+%28HIV%29+subtypes+on+HIV-associated+neurological+disease.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">25.
              </span><a name="pone.0001971-Wong1" id="pone.0001971-Wong1"></a>Wong MH, Robertson K, Nakasujja N, Skolasky R, Musisi S, et al.  (2007) Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa. Neurology  68: 350–355.  <ul class="find" data-citedArticleID="1089540" data-doi="10.1212/01.wnl.0000252811.48891.6d"><li><a href="http://dx.doi.org/10.1212/01.wnl.0000252811.48891.6d" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Frequency+of+and+risk+factors+for+HIV+dementia+in+an+HIV+clinic+in+sub-Saharan+Africa." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Frequency+of+and+risk+factors+for+HIV+dementia+in+an+HIV+clinic+in+sub-Saharan+Africa.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">26.
              </span><a name="pone.0001971-Yepthomi1" id="pone.0001971-Yepthomi1"></a>Yepthomi T, Paul R, Vallabhaneni S, Kumarasamy N, Tate DF, et al.  (2006) Neurocognitive consequences of HIV in southern India: a preliminary study of clade C virus. J Int Neuropsychol Soc  12: 424–430.  <ul class="find" data-citedArticleID="1089542" data-doi="10.1017/s1355617706060516"><li><a href="http://dx.doi.org/10.1017/s1355617706060516" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Neurocognitive+consequences+of+HIV+in+southern+India%3A+a+preliminary+study+of+clade+C+virus." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Neurocognitive+consequences+of+HIV+in+southern+India%3A+a+preliminary+study+of+clade+C+virus.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">27.
              </span><a name="pone.0001971-Sacktor1" id="pone.0001971-Sacktor1"></a>Sacktor N, Nakasujja N, Robertson K, Clifford DB (2007) HIV-associated cognitive impairment in sub-Saharan Africa–the potential effect of clade diversity. Nat Clin Pract Neurol  3: 436–443.  <ul class="find" data-citedArticleID="1089530" data-doi="10.1038/ncpneuro0559"><li><a href="http://dx.doi.org/10.1038/ncpneuro0559" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=HIV-associated+cognitive+impairment+in+sub-Saharan+Africa%E2%80%93the+potential+effect+of+clade+diversity." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22HIV-associated+cognitive+impairment+in+sub-Saharan+Africa%E2%80%93the+potential+effect+of+clade+diversity.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">28.
              </span><a name="pone.0001971-HagbergL1" id="pone.0001971-HagbergL1"></a>Hagberg L AL-M, Abdulle S, Gisslen M (2004) Clinical application of cerebrospinal fluid neopterin concentrations in HIV infection. Pteridines 102–106.  <ul class="find" data-citedArticleID="1089508" data-doi="10.1515/pteridines.2004.15.3.102"><li><a href="http://dx.doi.org/10.1515/pteridines.2004.15.3.102" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Clinical+application+of+cerebrospinal+fluid+neopterin+concentrations+in+HIV+infection." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Clinical+application+of+cerebrospinal+fluid+neopterin+concentrations+in+HIV+infection.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">29.
              </span><a name="pone.0001971-Shafer1" id="pone.0001971-Shafer1"></a>Shafer RW, Jung DR, Betts BJ, Xi Y, Gonzales MJ (2000) Human immunodeficiency virus reverse transcriptase and protease sequence database. Nucleic Acids Res  28: 346–348.  <ul class="find" data-citedArticleID="1089532" data-doi="10.1093/nar/28.1.346"><li><a href="http://dx.doi.org/10.1093/nar/28.1.346" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Human+immunodeficiency+virus+reverse+transcriptase+and+protease+sequence+database." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Human+immunodeficiency+virus+reverse+transcriptase+and+protease+sequence+database.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">30.
              </span><a name="pone.0001971-Gissln1" id="pone.0001971-Gissln1"></a>Gisslén M, Fuchs D, Svennerholm B, Hagberg L (1999) Cerebrospinal fluid viral load, intrathecal immunoactivation, and cerebrospinal fluid monocytic cell count in HIV-1 infection. J Acquir Immune Defic Syndr  21: 271–276.  <ul class="find" data-citedArticleID="1089504" data-doi="10.1097/00126334-199908010-00003"><li><a href="http://dx.doi.org/10.1097/00126334-199908010-00003" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Cerebrospinal+fluid+viral+load%2C+intrathecal+immunoactivation%2C+and+cerebrospinal+fluid+monocytic+cell+count+in+HIV-1+infection." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Cerebrospinal+fluid+viral+load%2C+intrathecal+immunoactivation%2C+and+cerebrospinal+fluid+monocytic+cell+count+in+HIV-1+infection.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">31.
              </span><a name="pone.0001971-Spudich1" id="pone.0001971-Spudich1"></a>Spudich SS, Nilsson AC, Lollo ND, Liegler TJ, Petropoulos CJ, et al.  (2005) Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment. BMC Infect Dis  5: 98.  <ul class="find" data-citedArticleID="1089534"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Cerebrospinal+fluid+HIV+infection+and+pleocytosis%3A+relation+to+systemic+infection+and+antiretroviral+treatment.&amp;auth=&amp;atitle=Cerebrospinal+fluid+HIV+infection+and+pleocytosis%3A+relation+to+systemic+infection+and+antiretroviral+treatment." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Cerebrospinal+fluid+HIV+infection+and+pleocytosis%3A+relation+to+systemic+infection+and+antiretroviral+treatment." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Cerebrospinal+fluid+HIV+infection+and+pleocytosis%3A+relation+to+systemic+infection+and+antiretroviral+treatment.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li></ol></div>

  </div>

      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001971.XML" value="58646"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001971.PDF" value="645815"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001971.t001.PNG_L" value="121162"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001971.t001.PNG_M" value="69189"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001971.t001.PNG_S" value="12205"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001971.t001.TIF" value="776816"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001971.t001.PNG_I" value="21304"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001971.g001.PNG_L" value="378325"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001971.g001.PNG_M" value="130189"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001971.g001.PNG_S" value="13778"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001971.g001.TIF" value="703762"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001971.g001.PNG_I" value="42594"/>

</div>
<div class="sidebar">

  <div class="article-actions cf">
      <div class="download">
        <span class="btn"><a href="/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0001971&amp;representation=PDF" title="Download" target="_blank">Download PDF</a></span>
      </div>
      <div class="btn-reveal dropdown">
        <div class="dropdown-icon">
          <span class="btn">&nbsp;</span>
        </div>

        <div class="content">
          <ul class="bullet">
            <li><a href="/article/citationList.action?articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0001971" title="Download citations">Citation</a></li>
            <li><a href="/article/fetchObjectAttachment.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0001971&amp;representation=XML" title="Download article XML">XML</a></li>
          </ul>
        </div>
      </div> <!-- end btn-reveal dropdown-->


    <div class="btn-reveal flt-l">
        <span class="btn">Print</span>
        <div class="content">
            <ul class="bullet">
                <li id="print-article"><a href="#" onclick="if(typeof(_gaq) != 'undefined'){ _gaq.push(['_trackEvent','Article', 'Print', 'Click']); } window.print(); return false;" title="Print Article">Print article</a></li>
                <li>
                  <a href="https://www.odysseypress.com/onlinehost/reprint_order.php?type=A&page=0&journal=7&doi=10.1371/journal.pone.0001971&volume=&issue=&title=Cerebrospinal Fluid Viral Load and Intrathecal Immune Activation in Individuals Infected with Different HIV-1 Genetic Subtypes&author_name=Sahra%20Abdulle%2C%20Lars%20Hagberg%2C%20Bo%20Svennerholm%2C%20Dietmar%20Fuchs%2C%20Magnus%20Gissl%C3%A9n&start_page=1&end_page=5" title="Odyssey Press">EzReprint</a>
                </li>
            </ul>
        </div>
    </div>

    <div class="btn-reveal flt-r">
        <span class="btn">Share</span>
        <div class="content">
            <ul class="social">
                <li><a href="http://www.reddit.com/submit?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001971" target="_blank" title="Submit to Reddit"><img src="/images/icon.reddit.16.png" width="16" height="16" alt="Reddit">Reddit</a></li>

                <li><a href="https://plus.google.com/share?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001971" target="_blank" title="Share on Google+"><img src="/images/icon.gplus.16.png" width="16" height="16" alt="Google+">Google+</a></li>

                <li><a href="http://www.stumbleupon.com/submit?url=http%3A%2F%2Fwww.plosone.org%2Farticle%2Finfo%253Adoi%252F10.1371%252Fjournal.pone.0001971" target="_blank" title="Add to StumbleUpon"><img src="/images/icon.stumble.16.png" width="16" height="16" alt="StumbleUpon">StumbleUpon</a></li>

                <li><a href="http://www.facebook.com/share.php?u=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001971&amp;t=Cerebrospinal%20Fluid%20Viral%20Load%20and%20Intrathecal%20Immune%20Activation%20in%20Individuals%20Infected%20with%20Different%20HIV-1%20Genetic%20Subtypes" target="_blank" title="Share on Facebook"><img src="/images/icon.fb.16.png" width="16" height="16" alt="Facebook">Facebook</a></li>

                <li><a href="http://www.linkedin.com/shareArticle?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001971&title=Cerebrospinal%20Fluid%20Viral%20Load%20and%20Intrathecal%20Immune%20Activation%20in%20Individuals%20Infected%20with%20Different%20HIV-1%20Genetic%20Subtypes&summary=Checkout%20this%20article%20I%20found%20at%20PLOS" target="_blank" title="Add to LinkedIn"><img src="/images/icon.linkedin.16.png" width="16" height="16" alt="Mendeley">LinkedIn</a></li>

                <li><a href="http://www.citeulike.org/posturl?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001971&amp;title=Cerebrospinal%20Fluid%20Viral%20Load%20and%20Intrathecal%20Immune%20Activation%20in%20Individuals%20Infected%20with%20Different%20HIV-1%20Genetic%20Subtypes" target="_blank" title="Add to CiteULike"><img src="/images/icon.cul.16.png" width="16" height="16" alt="CiteULike">CiteULike</a></li>

                <li><a href="http://www.mendeley.com/import/?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001971" target="_blank" title="Add to Mendeley"><img src="/images/icon.mendeley.16.png" width="16" height="16" alt="Mendeley">Mendeley</a></li>

                <li><a href="https://www.pubchase.com/library?add_aid=10.1371%2Fjournal.pone.0001971&amp;source=plos" target="_blank" title="Add to PubChase"><img src="/images/icon.pc.16.png" width="16" height="16" alt="PubChase">PubChase</a></li>


                <script type="text/javascript">
                    // replace tweet with one that's pre-shortened to 140 chars
                    function truncateTweetText() {
                        var twtTitle = 'Cerebrospinal Fluid Viral Load and Intrathecal Immune Activation in Individuals Infected with Different HIV-1 Genetic Subtypes';
                        var twtUrl = 'http://dx.plos.org/10.1371/journal.pone.0001971';
                        // all URLs posted to twitter get auto-shortened to 20 chars.
                        var maxLength = 140 - (20 + 1);
                        // truncate the title to include space for twtTag and ellipsis (here, 10 = tag length + space + ellipsis)
                        if (twtTitle.length > maxLength) { twtTitle = twtTitle.substr(0, (maxLength - 10)) + '...'; }
                        // set the href to use the shortened tweet
                        $('#twitter-share-link').prop('href', 'http://twitter.com/intent/tweet?text=' + encodeURIComponent('#PLOSONE: ' + twtTitle + ' ' + twtUrl));
                    }
                </script>
                <li><a href="http://twitter.com/intent/tweet?text=#PLOSONE%3A%20Cerebrospinal%20Fluid%20Viral%20Load%20and%20Intrathecal%20Immune%20Activation%20in%20Individuals%20Infected%20with%20Different%20HIV-1%20Genetic%20Subtypes http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001971" onclick="truncateTweetText();" target="_blank" title="Share on Twitter" id="twitter-share-link"><img src="/images/icon.twtr.16.png" width="16" height="16" alt="Twitter">Twitter</a></li>

                <li><a href="/article/email/info%3Adoi%2F10.1371%2Fjournal.pone.0001971" title="Email this article"><img src="/images/icon.email.16.png" width="16" height="16" alt="Email">Email</a></li>
            </ul>
        </div>
    </div><!--end btn-reveal flt-r-->
</div><!-- end article-actions-->

<!-- begin Crossmark -->

<a id="open-crossmark" href="#" style="margin-top: -28px; display:block"><img style="border: 0; display: none;
 padding: 10px 0 18px 0;"  id="crossmark-icon" src="/images/logo-crossmark-bw.png" /></a>
<div id="crossmark-dialog" style="display: none;" title="">
    <!-- the external CrossMark data is loaded inside this iframe -->
    <iframe id="crossmark-dialog-frame" frameborder="0"></iframe>
</div>

<!-- end crossmark -->


<div class="block" id="subject-area-sidebar-block">
    <div class="header">
        <h3>Subject Areas</h3><div title="More information" id="subject-area-sidebar-block-help-icon"><img align="right"
                                                                                                           alt="info" src="/images/button_info.png"/><div id="subject-area-sidebar-block-help"><img align="right"
                                                                                                                                                                                                    src="/images/button_info.png"/><p>
        <b>We want your feedback.</b> Do these subject areas make sense for this article? If not, click the flag
        next to the incorrect subject area and we will review it. Thanks for your help!
    </p></div></div>
    </div>


    <ul id="subject-area-sidebar-list">
























          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Blood+plasma%22" title="Search for articles in the subject area:'Blood plasma'"><div class="flagText">Blood plasma</div></a>
              <div data-categoryid="32385" data-articleid="26766"
                   data-categoryname="Blood plasma"
                   class="flagImage" title="Flag 'Blood plasma' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Central+nervous+system%22" title="Search for articles in the subject area:'Central nervous system'"><div class="flagText">Central nervous system</div></a>
              <div data-categoryid="47337" data-articleid="26766"
                   data-categoryname="Central nervous system"
                   class="flagImage" title="Flag 'Central nervous system' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Cerebrospinal+fluid%22" title="Search for articles in the subject area:'Cerebrospinal fluid'"><div class="flagText">Cerebrospinal fluid</div></a>
              <div data-categoryid="48641" data-articleid="26766"
                   data-categoryname="Cerebrospinal fluid"
                   class="flagImage" title="Flag 'Cerebrospinal fluid' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22HIV-1%22" title="Search for articles in the subject area:'HIV-1'"><div class="flagText">HIV-1</div></a>
              <div data-categoryid="42865" data-articleid="26766"
                   data-categoryname="HIV-1"
                   class="flagImage" title="Flag 'HIV-1' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Opportunistic+infections%22" title="Search for articles in the subject area:'Opportunistic infections'"><div class="flagText">Opportunistic infections</div></a>
              <div data-categoryid="48457" data-articleid="26766"
                   data-categoryname="Opportunistic infections"
                   class="flagImage" title="Flag 'Opportunistic infections' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Polymerase+chain+reaction%22" title="Search for articles in the subject area:'Polymerase chain reaction'"><div class="flagText">Polymerase chain reaction</div></a>
              <div data-categoryid="26251" data-articleid="26766"
                   data-categoryname="Polymerase chain reaction"
                   class="flagImage" title="Flag 'Polymerase chain reaction' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22RNA+alignment%22" title="Search for articles in the subject area:'RNA alignment'"><div class="flagText">RNA alignment</div></a>
              <div data-categoryid="32671" data-articleid="26766"
                   data-categoryname="RNA alignment"
                   class="flagImage" title="Flag 'RNA alignment' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22RNA+sequence+analysis%22" title="Search for articles in the subject area:'RNA sequence analysis'"><div class="flagText">RNA sequence analysis</div></a>
              <div data-categoryid="47581" data-articleid="26766"
                   data-categoryname="RNA sequence analysis"
                   class="flagImage" title="Flag 'RNA sequence analysis' as inappropriate"></div>
          </li>
    </ul>
</div>

<div class="ad">
    <div class="title">Advertisement</div>






  <iframe id='a0852f54' name='a0852f54'
    src='http://ads.plos.org/www/delivery/afr.php?zoneid=381&amp;cb=9293'
    frameborder='0' scrolling='no' width='160' height='600'>
    <a href='http://ads.plos.org/www/delivery/ck.php?n=a0852f54&amp;cb=104'
      target='_top'><img src='http://ads.plos.org/www/delivery/avw.php?zoneid=381&amp;cb=5322&amp;n=a0852f54'
      border='0' alt=''/>
    </a>
  </iframe>



</div>

<div id="twitter-alm-timeline" class="twitter-alm-timeline"></div>


</div><!-- sidebar -->
    </div>
  </div>
</div>
<script src="http://wl.figshare.com/static/p_widget.js" type="text/javascript"></script><div id="pageftr">
  <div class="ftr-cols cf">
    <div class="col col-1">
      <img src="/images/logo-plos-footer.png" alt="PLOS Logo" class="logo" />
      <p><a href="/static/releaseNotes">Ambra 2.9.16</a> Managed Colocation provided <br />by <a href="http://www.isc.org/">Internet Systems Consortium</a>.<p>
      <div class="nav nav-aux">
        <a href="/static/privacy">Privacy Policy</a> |
        <a href="/static/terms">Terms of Use</a> |
        <a href="http://www.plos.org/advertise/">Advertise</a> |
        <a href="http://www.plos.org/about/media-inquiries/">Media Inquiries</a>
      </div>
    </div>
    <div class="col col-2">
      <p><a href="http://www.plos.org/publications/journals/">Publications</a></p>
      <div class="nav">
        <ul>
          <li><a href="http://www.plosbiology.org">PLOS Biology</a></li>
          <li><a href="http://www.plosmedicine.org">PLOS Medicine</a></li>
          <li><a href="http://www.ploscompbiol.org">PLOS Computational Biology</a></li>
          <li><a href="http://currents.plos.org">PLOS Currents</a></li>
          <li><a href="http://www.plosgenetics.org">PLOS Genetics</a></li>
          <li><a href="http://www.plospathogens.org">PLOS Pathogens</a></li>
          <li><a href="http://www.plosone.org">PLOS ONE</a></li>
          <li><a href="http://www.plosntds.org">PLOS Neglected Tropical Diseases</a></li>
        </ul>
      </div>
    </div>
    <div class="col col-3">
      <div class="nav">
        <p><a href="http://www.plos.org">plos.org</a></p>
        <p><a href="http://blogs.plos.org">Blogs</a></p>
        <p><a href="http://www.ploscollections.org">Collections</a></p>
        <p><a href="/feedback/new">Send us feedback</a></p>

        <p>California (US) corporation #C2354500, based in San Francisco</p>
      </div>
    </div>
  </div>
</div><!-- pageftr -->

</div><!-- end page-wrap, this div is in header.ftl -->
<script type="text/javascript" src="/javascript/jquery-1.8.1-min.js?v=Tm7VCOzZz3lE03ghpkS6SWkHbyI"></script>
<script type="text/javascript" src="/javascript/ga-min.js?v=lNQ4gt8QcPDatjsdOFl_FGpPhLY"></script>
<script type="text/javascript" src="/javascript/jquery.hoverIntent-min.js?v=mRiGNYY9cIXxVb8u0K_MdW7hHnc"></script>
<script type="text/javascript" src="/javascript/jquery.placeholder-min.js?v=21Pn56Ur9h1N4K4VZDa0nqI3Pxo"></script>
<script type="text/javascript" src="/javascript/jquery.jsonp-2.4.0-min.js?v=lqTpzoHfSq3I5Ygo01qq5WankEo"></script>
<script type="text/javascript" src="/javascript/jquery-ui-1.9.2.custom-min.js?v=raSSlfNO0YsV5uUpAKmTB9n5VTc"></script>
<script type="text/javascript" src="/javascript/jquery.tooltip-min.js?v=cw+6Smh+mdryIA25xvqIvHMrnZM"></script>
<script type="text/javascript" src="/javascript/jquery.uniform-min.js?v=kYUAnX6W2W_2fK3RIuQ2m_YFG9U"></script>
<script type="text/javascript" src="/javascript/jquery.pjax-min.js?v=939kLBjL5_YKbx71T1RHjYaD4l8"></script>
<script type="text/javascript" src="/javascript/imagesloaded-min.js?v=XeuAp8Gc3mvQUo+wZCSF8ttPwvw"></script>
<script type="text/javascript" src="/javascript/figviewer-min.js?v=yPUa0sUQ_iHkI+IRv2i9bjyZJFo"></script>
<script type="text/javascript" src="/javascript/global-min.js?v=0Q3PwjeaWtXYDnqIsQvnL_ou0qs"></script>
<script type="text/javascript" src="/javascript/jquery.touchswipe-min.js?v=huaek_e6HqTduvCNAN91dJolTyw"></script>
<script type="text/javascript" src="/javascript/jquery.base64-min.js?v=VwV1zeVqKZj5FCAdlK0q5NRxbBg"></script>
<script type="text/javascript" src="/javascript/alm-min.js?v=Y5gm6B0b4Kx2YHNObNrgEeBgXlY"></script>
<script type="text/javascript" src="/javascript/taxonomy-browser-min.js?v=vBVMuDMYkGJCXIUxLe35GoyiJNw"></script>
<script type="text/javascript" src="/javascript/jquery.filterize-min.js?v=j0ZKVnHyk2nhFy8eIuNJkp7xaM0"></script>
<script type="text/javascript" src="/javascript/plosone-min.js?v=TK4H4arL_XBSwwJq+K1N3kqYfAI"></script>
<script type="text/javascript" src="/javascript/twitter-min.js?v=xKgcxLsQFXy+at1ao1NVke8nFlM"></script>
<script type="text/javascript" src="/javascript/crossmark.1.4-min.js?v=3FO4k0SjwTaGNnKGNSqthar1080"></script>
<script type="text/javascript">
  var _sf_async_config={uid:16579,domain:"plosone.org"};
  (function(){
    function loadChartbeat() {
      window._sf_endpt=(new Date()).getTime();
      var e = document.createElement('script');
      e.setAttribute('language', 'javascript');
      e.setAttribute('type', 'text/javascript');
      e.setAttribute('src',
          (("https:" == document.location.protocol) ? "https://a248.e.akamai.net/chartbeat.download.akamai.com/102508/" : "http://static.chartbeat.com/") +
              "js/chartbeat.js");
      document.body.appendChild(e);
    }
    var oldonload = window.onload;
    window.onload = (typeof window.onload != 'function') ?
        loadChartbeat : function() { oldonload(); loadChartbeat(); };
  })();
</script>
<!-- <script type="application/javascript" src="http://crossmark.crossref.org/javascripts/v1.3/crossmark.min.js"></script> -->

</body>
</html>
